Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Nektar Therapeutics (“Nektar” or the “Company”) (NASDAQ: NKTR) investors of an ...
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 13, 2026 to file lead plaintiff applications in a ...
Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する